APA

Rades D., Seidl D., Janssen S., Bajrovic A., Hakim S. G., Wollenberg B., Karner K., Strojan P. & Schild S. E. (20180314). Chemoradiation of locally advanced squamous cell carcinoma of the head-and-neck (LASCCHN): Is 20mg/m(2) cisplatin on five days every four weeks an alternative to 100mg/m(2) cisplatin every three weeks?. : Oral oncology.

Chicago

Rades Dirk, Seidl Daniel, Janssen Stefan, Bajrovic Amira, Hakim Samer G, Wollenberg Barbara, Karner Katarina, Strojan Primoz and Schild Steven E. 20180314. Chemoradiation of locally advanced squamous cell carcinoma of the head-and-neck (LASCCHN): Is 20mg/m(2) cisplatin on five days every four weeks an alternative to 100mg/m(2) cisplatin every three weeks?. : Oral oncology.

Harvard

Rades D., Seidl D., Janssen S., Bajrovic A., Hakim S. G., Wollenberg B., Karner K., Strojan P. and Schild S. E. (20180314). Chemoradiation of locally advanced squamous cell carcinoma of the head-and-neck (LASCCHN): Is 20mg/m(2) cisplatin on five days every four weeks an alternative to 100mg/m(2) cisplatin every three weeks?. : Oral oncology.

MLA

Rades Dirk, Seidl Daniel, Janssen Stefan, Bajrovic Amira, Hakim Samer G, Wollenberg Barbara, Karner Katarina, Strojan Primoz and Schild Steven E. Chemoradiation of locally advanced squamous cell carcinoma of the head-and-neck (LASCCHN): Is 20mg/m(2) cisplatin on five days every four weeks an alternative to 100mg/m(2) cisplatin every three weeks?. : Oral oncology. 20180314.